Saatja: Obon Roger <
[email protected]>
Saaja: Esindus EL juures üldaadress, Nominations
Teema: Estonia - 2020-11-20 - Nomination invitation for CAT alternate
For the attention of HE Mr Rein Tammsaar,
Your Excellency,
Please find attached a letter from the Executive Director of the European Medicines Agency regarding the nomination of representatives in the Committee for Advanced Therapies (CAT).
Kind Regards,
[3-EMA banner - option 1]<https://www.ema.europa.eu/en/about-us/history-ema>
Roger Obon
Experts and Declarations of Interests Management
Meeting Secretariat Office
Committees and Quality Assurance Department
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Telephone +31 (0)88 781 6763
[email protected]<mailto:
[email protected]> | www.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>
Follow us: [Twitter-icon] <https://twitter.com/EMA_News> [RSS-icon] <https://www.ema.europa.eu/en/news-event/rss-feeds> [Youtube-icon] <https://www.youtube.com/user/emainfo>
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.
P Please consider the environment before printing this e-mail
Classified as confidential by the European Medicines Agency
________________________________________________________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
________________________________________________________________________
Saatja: Webdesktop <
[email protected]>
Saadetud: 23.11.2020 13:55
Adressaat: SM Info <
[email protected]>; info ravimiamet ee <
[email protected]>;
<
[email protected]>; Elen Ohov <
[email protected]>
Koopia: <
[email protected]>
Teema: Webdesktop: Kiri nr 14-4/1123 / Eesti esindaja (CAT alternate)
nimetamine Euroopa Ravimiameti uudsete ravimite komiteesse
Tere!Edastan Euroopa Ravimiameti kirja. Palun andke enne 01.02.2021 EV
AEEL-le teada (
[email protected], cc:
[email protected]), kas me
pikendame praeguse asendusliikme Pille Saaliku mandaati või nimetame
uue.Infoks, et just sai pikendatud põhiliikme prof Toivo Maimetsa
liikmesust.Reg. number: 14-4/1123Reg. kuupäev: 23.11.2020Sisu: Eesti
esindaja nimetamine Euroopa Ravimiameti uudsete ravimite komiteesse (CAT
- Committee for Advanced Therapies)Nomination of representatives in the
Committee for Advanced Therapies (CAT) of the European Medicines
AgencyHeade soovidegaTiiu
[email protected]är EV AEEL juures